The Baveno Cooperation: an EASL Consortium
@bavenocoop.bsky.social
The official account of the Baveno Cooperation
📢First BavenoVIII deadline approaching ->Early bird registration ends 15 Dec 2025‼️
Key info:
🗓️ 27–28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 Hybrid format — in person or online
🧠 Abstracts opened until Jan 15!
🔗 baveno8.org/registration
More👇
Key info:
🗓️ 27–28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 Hybrid format — in person or online
🧠 Abstracts opened until Jan 15!
🔗 baveno8.org/registration
More👇
November 26, 2025 at 5:38 PM
📢First BavenoVIII deadline approaching ->Early bird registration ends 15 Dec 2025‼️
Key info:
🗓️ 27–28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 Hybrid format — in person or online
🧠 Abstracts opened until Jan 15!
🔗 baveno8.org/registration
More👇
Key info:
🗓️ 27–28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 Hybrid format — in person or online
🧠 Abstracts opened until Jan 15!
🔗 baveno8.org/registration
More👇
🚨Just 10 days away ‼️
Join the VALDIG PSVD Meeting 2025 in Paris
🗓️ Dec 4–5 @ CNAM
💶 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration → app.evalandgo.com/f/325218/4qE... Updated program below 👇
Join the VALDIG PSVD Meeting 2025 in Paris
🗓️ Dec 4–5 @ CNAM
💶 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration → app.evalandgo.com/f/325218/4qE... Updated program below 👇
November 24, 2025 at 3:44 PM
🚨Just 10 days away ‼️
Join the VALDIG PSVD Meeting 2025 in Paris
🗓️ Dec 4–5 @ CNAM
💶 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration → app.evalandgo.com/f/325218/4qE... Updated program below 👇
Join the VALDIG PSVD Meeting 2025 in Paris
🗓️ Dec 4–5 @ CNAM
💶 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration → app.evalandgo.com/f/325218/4qE... Updated program below 👇
🚨Just 3 weeks away‼️
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration → app.evalandgo.com/f/325218/4qE...
📘 Updated program below 👇
#LiverTwitter
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration → app.evalandgo.com/f/325218/4qE...
📘 Updated program below 👇
#LiverTwitter
November 13, 2025 at 8:29 AM
🚨Just 3 weeks away‼️
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration → app.evalandgo.com/f/325218/4qE...
📘 Updated program below 👇
#LiverTwitter
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration → app.evalandgo.com/f/325218/4qE...
📘 Updated program below 👇
#LiverTwitter
🎬 Want to know why you should register for the VALDIG PSVD Meeting 2025 in Paris 🇫🇷?
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
Watch the video below and see why you can’t miss it!
🔗 Register here: app.evalandgo.com/f/325218/4qE...
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
Watch the video below and see why you can’t miss it!
🔗 Register here: app.evalandgo.com/f/325218/4qE...
November 6, 2025 at 12:09 PM
🎬 Want to know why you should register for the VALDIG PSVD Meeting 2025 in Paris 🇫🇷?
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
Watch the video below and see why you can’t miss it!
🔗 Register here: app.evalandgo.com/f/325218/4qE...
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
Watch the video below and see why you can’t miss it!
🔗 Register here: app.evalandgo.com/f/325218/4qE...
🚨Just one month away‼️
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration -> app.evalandgo.com/f/325218/4qE...
📘 Full program below 👇 #LiverTwitter
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration -> app.evalandgo.com/f/325218/4qE...
📘 Full program below 👇 #LiverTwitter
November 5, 2025 at 4:03 PM
🚨Just one month away‼️
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration -> app.evalandgo.com/f/325218/4qE...
📘 Full program below 👇 #LiverTwitter
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online FREE
👉 Organized by EURO-VALDIG NET & FILFOIE
🔗 Registration -> app.evalandgo.com/f/325218/4qE...
📘 Full program below 👇 #LiverTwitter
💶Fees (VAT included)
In-person:
🧑🔬 Early bird: €800 → After: €1000
👩⚕️ Nurses/HCA: €500
🎓 Young investigators (<40 yrs): €700
👶 Symposium only: €122
Virtual:
🌐 General: €800
🎓 €500
@BavenoCoop
members: €100 off (except 🎓)
Register at: baveno8.org/registration
In-person:
🧑🔬 Early bird: €800 → After: €1000
👩⚕️ Nurses/HCA: €500
🎓 Young investigators (<40 yrs): €700
👶 Symposium only: €122
Virtual:
🌐 General: €800
🎓 €500
@BavenoCoop
members: €100 off (except 🎓)
Register at: baveno8.org/registration
October 27, 2025 at 1:45 PM
💶Fees (VAT included)
In-person:
🧑🔬 Early bird: €800 → After: €1000
👩⚕️ Nurses/HCA: €500
🎓 Young investigators (<40 yrs): €700
👶 Symposium only: €122
Virtual:
🌐 General: €800
🎓 €500
@BavenoCoop
members: €100 off (except 🎓)
Register at: baveno8.org/registration
In-person:
🧑🔬 Early bird: €800 → After: €1000
👩⚕️ Nurses/HCA: €500
🎓 Young investigators (<40 yrs): €700
👶 Symposium only: €122
Virtual:
🌐 General: €800
🎓 €500
@BavenoCoop
members: €100 off (except 🎓)
Register at: baveno8.org/registration
Important Deadlines for #BavenoVIII ‼️
💶 Early registration: 15 Dec 2025
🪶 Abstract submission: 15 Jan 2026
📄 Satellite programmes & speakers: 15 Jan 2026
📦 Sponsor material delivery at venue: 20 Mar 2026
Stay tuned for updates -> 🔗 baveno8.org
#LiverTwitter
💶 Early registration: 15 Dec 2025
🪶 Abstract submission: 15 Jan 2026
📄 Satellite programmes & speakers: 15 Jan 2026
📦 Sponsor material delivery at venue: 20 Mar 2026
Stay tuned for updates -> 🔗 baveno8.org
#LiverTwitter
October 27, 2025 at 1:45 PM
Important Deadlines for #BavenoVIII ‼️
💶 Early registration: 15 Dec 2025
🪶 Abstract submission: 15 Jan 2026
📄 Satellite programmes & speakers: 15 Jan 2026
📦 Sponsor material delivery at venue: 20 Mar 2026
Stay tuned for updates -> 🔗 baveno8.org
#LiverTwitter
💶 Early registration: 15 Dec 2025
🪶 Abstract submission: 15 Jan 2026
📄 Satellite programmes & speakers: 15 Jan 2026
📦 Sponsor material delivery at venue: 20 Mar 2026
Stay tuned for updates -> 🔗 baveno8.org
#LiverTwitter
⏳ Just 5 months left for #BavenoVIII!
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵
October 27, 2025 at 1:45 PM
⏳ Just 5 months left for #BavenoVIII!
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵
🗓️ 27-28 March 2026 (👶 Pediatric Symposium: 29 March)
📍 Baveno, Italy
🌐 The event will take place in a hybrid formula — both in person and online.
🧠 Call for abstracts is now open!
🔗 More info at: baveno8.org
🧵
🔬 Passionate about vascular liver diseases?
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷!
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online free
👉 Organized by EURO-VALDIG NET & FILFOIE
Register here ➡️ app.evalandgo.com/f/325218/4qE...
Full program 👇
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷!
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online free
👉 Organized by EURO-VALDIG NET & FILFOIE
Register here ➡️ app.evalandgo.com/f/325218/4qE...
Full program 👇
October 15, 2025 at 5:30 AM
🔬 Passionate about vascular liver diseases?
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷!
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online free
👉 Organized by EURO-VALDIG NET & FILFOIE
Register here ➡️ app.evalandgo.com/f/325218/4qE...
Full program 👇
Join the VALDIG PSVD Meeting 2025 in Paris 🇫🇷!
🗓️ Dec 4–5 @ CNAM
💳 Onsite €150 | 💻 Online free
👉 Organized by EURO-VALDIG NET & FILFOIE
Register here ➡️ app.evalandgo.com/f/325218/4qE...
Full program 👇
🚨 Join us for the VALDIG PSVD Meeting – a 2-day event dedicated to PSVD!
🗓️ Dec 4–5, 2025
📍 CNAM, Paris 🇫🇷
💳 Onsite €150 (payment after reg.) | Online free
👉Organized by EURO-VALDIG NET & FILFOIE
Register here ➡️ app.evalandgo.com/f/325218/4qE...
Program 👇
🗓️ Dec 4–5, 2025
📍 CNAM, Paris 🇫🇷
💳 Onsite €150 (payment after reg.) | Online free
👉Organized by EURO-VALDIG NET & FILFOIE
Register here ➡️ app.evalandgo.com/f/325218/4qE...
Program 👇
October 1, 2025 at 11:49 AM
🚨 Join us for the VALDIG PSVD Meeting – a 2-day event dedicated to PSVD!
🗓️ Dec 4–5, 2025
📍 CNAM, Paris 🇫🇷
💳 Onsite €150 (payment after reg.) | Online free
👉Organized by EURO-VALDIG NET & FILFOIE
Register here ➡️ app.evalandgo.com/f/325218/4qE...
Program 👇
🗓️ Dec 4–5, 2025
📍 CNAM, Paris 🇫🇷
💳 Onsite €150 (payment after reg.) | Online free
👉Organized by EURO-VALDIG NET & FILFOIE
Register here ➡️ app.evalandgo.com/f/325218/4qE...
Program 👇
🚨 Mark your calendars! Baveno VIII Meeting → 27–28 March 2026
Reminder from @crisripoll.bsky.social, Baveno Vice-Secretary at #DGVS
⏳ only 6 months left!
Register 👉 bavenocoop.net
Reminder from @crisripoll.bsky.social, Baveno Vice-Secretary at #DGVS
⏳ only 6 months left!
Register 👉 bavenocoop.net
September 19, 2025 at 3:25 PM
🚨 Mark your calendars! Baveno VIII Meeting → 27–28 March 2026
Reminder from @crisripoll.bsky.social, Baveno Vice-Secretary at #DGVS
⏳ only 6 months left!
Register 👉 bavenocoop.net
Reminder from @crisripoll.bsky.social, Baveno Vice-Secretary at #DGVS
⏳ only 6 months left!
Register 👉 bavenocoop.net
The passing of Prof. Jaume Bosch (1947–2025) has generated, and continues to generate, heartfelt tributes
Here you can read some of them:
Scientific societies
🇪🇺EASL: journal-of-hepatology.eu/action/showP...
🇪🇸AEEH: aeeh.es/obituario-ja...
🇨🇭SASL: sasl.unibas.ch/files/mixed%...
Here you can read some of them:
Scientific societies
🇪🇺EASL: journal-of-hepatology.eu/action/showP...
🇪🇸AEEH: aeeh.es/obituario-ja...
🇨🇭SASL: sasl.unibas.ch/files/mixed%...
September 4, 2025 at 9:32 AM
The passing of Prof. Jaume Bosch (1947–2025) has generated, and continues to generate, heartfelt tributes
Here you can read some of them:
Scientific societies
🇪🇺EASL: journal-of-hepatology.eu/action/showP...
🇪🇸AEEH: aeeh.es/obituario-ja...
🇨🇭SASL: sasl.unibas.ch/files/mixed%...
Here you can read some of them:
Scientific societies
🇪🇺EASL: journal-of-hepatology.eu/action/showP...
🇪🇸AEEH: aeeh.es/obituario-ja...
🇨🇭SASL: sasl.unibas.ch/files/mixed%...
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation.
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
July 16, 2025 at 7:11 AM
🖤 With deep sorrow, we announce the passing of Prof. Dr. Jaime Bosch, President of the Baveno Cooperation.
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
A brilliant scientist, inspiring leader, and dear friend. His immense legacy in hepatology will endure.
Rest in peace, Jaime
💊 DOACs in cirrhosis
🗣️ Cindy Pereira Portela (Lausanne) – #EASL2025
✅ Child A/B: ok (⚠️ no rivaroxaban in B)
🚫 Child C: not recommended
⭐ Apixaban might be the winner — but more data needed
🧩 Case-by-case decision
🤝 Multidisciplinary approach is essential
🗣️ Cindy Pereira Portela (Lausanne) – #EASL2025
✅ Child A/B: ok (⚠️ no rivaroxaban in B)
🚫 Child C: not recommended
⭐ Apixaban might be the winner — but more data needed
🧩 Case-by-case decision
🤝 Multidisciplinary approach is essential
May 9, 2025 at 4:05 PM
💊 DOACs in cirrhosis
🗣️ Cindy Pereira Portela (Lausanne) – #EASL2025
✅ Child A/B: ok (⚠️ no rivaroxaban in B)
🚫 Child C: not recommended
⭐ Apixaban might be the winner — but more data needed
🧩 Case-by-case decision
🤝 Multidisciplinary approach is essential
🗣️ Cindy Pereira Portela (Lausanne) – #EASL2025
✅ Child A/B: ok (⚠️ no rivaroxaban in B)
🚫 Child C: not recommended
⭐ Apixaban might be the winner — but more data needed
🧩 Case-by-case decision
🤝 Multidisciplinary approach is essential
🩸 Managing acute bleeding in cirrhosis
🗣️ Lara Roberts (London) – #EASL2025
✅ Restrictive transfusion
🚫 No FFP, no tranexamic acid
❓ Platelets & fibrinogen: no clear evidence
🔮 Future: viscoelastic tests to guide therapy?
🗣️ Lara Roberts (London) – #EASL2025
✅ Restrictive transfusion
🚫 No FFP, no tranexamic acid
❓ Platelets & fibrinogen: no clear evidence
🔮 Future: viscoelastic tests to guide therapy?
May 9, 2025 at 3:55 PM
🩸 Managing acute bleeding in cirrhosis
🗣️ Lara Roberts (London) – #EASL2025
✅ Restrictive transfusion
🚫 No FFP, no tranexamic acid
❓ Platelets & fibrinogen: no clear evidence
🔮 Future: viscoelastic tests to guide therapy?
🗣️ Lara Roberts (London) – #EASL2025
✅ Restrictive transfusion
🚫 No FFP, no tranexamic acid
❓ Platelets & fibrinogen: no clear evidence
🔮 Future: viscoelastic tests to guide therapy?
🩸 Haemostatic management during procedures in cirrhosis
🗣️ N. Intagliata – #EASL2025
✅ Bleeding is rare, but serious
🚫 Standard tests ≠ bleeding risk
📌 Consider procedure risk, cirrhosis stage & BMI
📋 Have a bleeding plan
🧪 Viscoelastic tests: promising future tool
🗣️ N. Intagliata – #EASL2025
✅ Bleeding is rare, but serious
🚫 Standard tests ≠ bleeding risk
📌 Consider procedure risk, cirrhosis stage & BMI
📋 Have a bleeding plan
🧪 Viscoelastic tests: promising future tool
May 9, 2025 at 3:44 PM
🩸 Haemostatic management during procedures in cirrhosis
🗣️ N. Intagliata – #EASL2025
✅ Bleeding is rare, but serious
🚫 Standard tests ≠ bleeding risk
📌 Consider procedure risk, cirrhosis stage & BMI
📋 Have a bleeding plan
🧪 Viscoelastic tests: promising future tool
🗣️ N. Intagliata – #EASL2025
✅ Bleeding is rare, but serious
🚫 Standard tests ≠ bleeding risk
📌 Consider procedure risk, cirrhosis stage & BMI
📋 Have a bleeding plan
🧪 Viscoelastic tests: promising future tool
Do we need to treat cirrhotic PVT, and how? – #EASL2025
🗣️ @jcgarciapagan
📍 LT candidate → anticoagulate if >25%
🚫 No LT → consider if >50%
🔍 Anticoagulation may help beyond recanalization
🛠️ Radiological Rx: for LT candidates not responding or with refractory CSPH
🗣️ @jcgarciapagan
📍 LT candidate → anticoagulate if >25%
🚫 No LT → consider if >50%
🔍 Anticoagulation may help beyond recanalization
🛠️ Radiological Rx: for LT candidates not responding or with refractory CSPH
May 9, 2025 at 3:35 PM
Do we need to treat cirrhotic PVT, and how? – #EASL2025
🗣️ @jcgarciapagan
📍 LT candidate → anticoagulate if >25%
🚫 No LT → consider if >50%
🔍 Anticoagulation may help beyond recanalization
🛠️ Radiological Rx: for LT candidates not responding or with refractory CSPH
🗣️ @jcgarciapagan
📍 LT candidate → anticoagulate if >25%
🚫 No LT → consider if >50%
🔍 Anticoagulation may help beyond recanalization
🛠️ Radiological Rx: for LT candidates not responding or with refractory CSPH
🎓 Jean-Pierre Benhamou Clinical State-of-the-Art
🗣️ @docberza.bsky.social on The promise & pitfalls of non-invasive testing – #EASL2025
🧪 NITs: from fibrosis staging ➡️ to prognosis
📈 Last LSM value matters
🔬 OMICS + evolving algorithms = the future
⏳ Baveno VIII will guide next steps
🗣️ @docberza.bsky.social on The promise & pitfalls of non-invasive testing – #EASL2025
🧪 NITs: from fibrosis staging ➡️ to prognosis
📈 Last LSM value matters
🔬 OMICS + evolving algorithms = the future
⏳ Baveno VIII will guide next steps
May 9, 2025 at 3:18 PM
🎓 Jean-Pierre Benhamou Clinical State-of-the-Art
🗣️ @docberza.bsky.social on The promise & pitfalls of non-invasive testing – #EASL2025
🧪 NITs: from fibrosis staging ➡️ to prognosis
📈 Last LSM value matters
🔬 OMICS + evolving algorithms = the future
⏳ Baveno VIII will guide next steps
🗣️ @docberza.bsky.social on The promise & pitfalls of non-invasive testing – #EASL2025
🧪 NITs: from fibrosis staging ➡️ to prognosis
📈 Last LSM value matters
🔬 OMICS + evolving algorithms = the future
⏳ Baveno VIII will guide next steps
🏆 Community Award to @docberza.bsky.social (Bern, Switzerland) at #EASL2025
💬 Beautiful and emotional intro by @RodriguesSu24
🙏 So proud to have you in @bavenocoop.bsky.social
— well deserved!
#LiverTwitter
💬 Beautiful and emotional intro by @RodriguesSu24
🙏 So proud to have you in @bavenocoop.bsky.social
— well deserved!
#LiverTwitter
May 9, 2025 at 3:07 PM
🏆 Community Award to @docberza.bsky.social (Bern, Switzerland) at #EASL2025
💬 Beautiful and emotional intro by @RodriguesSu24
🙏 So proud to have you in @bavenocoop.bsky.social
— well deserved!
#LiverTwitter
💬 Beautiful and emotional intro by @RodriguesSu24
🙏 So proud to have you in @bavenocoop.bsky.social
— well deserved!
#LiverTwitter
🇬🇧 CALIBRE trial – D. Tripathi at #EASL2025
RCT: carvedilol vs VBL for 1º prevention in cirrhosis
🟰 No difference in bleeding or survival at 12 months
💊 Carvedilol safe, simpler & cost-effective
📉 Follow-up limited (12 mo), but extension planned
⚠️ Underpowered due to COVID
RCT: carvedilol vs VBL for 1º prevention in cirrhosis
🟰 No difference in bleeding or survival at 12 months
💊 Carvedilol safe, simpler & cost-effective
📉 Follow-up limited (12 mo), but extension planned
⚠️ Underpowered due to COVID
May 9, 2025 at 3:04 PM
🇬🇧 CALIBRE trial – D. Tripathi at #EASL2025
RCT: carvedilol vs VBL for 1º prevention in cirrhosis
🟰 No difference in bleeding or survival at 12 months
💊 Carvedilol safe, simpler & cost-effective
📉 Follow-up limited (12 mo), but extension planned
⚠️ Underpowered due to COVID
RCT: carvedilol vs VBL for 1º prevention in cirrhosis
🟰 No difference in bleeding or survival at 12 months
💊 Carvedilol safe, simpler & cost-effective
📉 Follow-up limited (12 mo), but extension planned
⚠️ Underpowered due to COVID
💉 Albumin duration & AKI response in cirrhosis
Eva M. Schleicher (Mainz) – #EASL2025
🕒 24h albumin new rule questioned
🏆 EASL AKI response definition wins
📈 20% of 24h NR improved at 48h
⚖️ Early vs late responders: Same mortality
🚨 Cr ↑ >16% @24h → terlipressin!
👇
Eva M. Schleicher (Mainz) – #EASL2025
🕒 24h albumin new rule questioned
🏆 EASL AKI response definition wins
📈 20% of 24h NR improved at 48h
⚖️ Early vs late responders: Same mortality
🚨 Cr ↑ >16% @24h → terlipressin!
👇
May 9, 2025 at 3:02 PM
💉 Albumin duration & AKI response in cirrhosis
Eva M. Schleicher (Mainz) – #EASL2025
🕒 24h albumin new rule questioned
🏆 EASL AKI response definition wins
📈 20% of 24h NR improved at 48h
⚖️ Early vs late responders: Same mortality
🚨 Cr ↑ >16% @24h → terlipressin!
👇
Eva M. Schleicher (Mainz) – #EASL2025
🕒 24h albumin new rule questioned
🏆 EASL AKI response definition wins
📈 20% of 24h NR improved at 48h
⚖️ Early vs late responders: Same mortality
🚨 Cr ↑ >16% @24h → terlipressin!
👇
🧪 Urinary NGAL in AKI & decompensated cirrhosis
María José Moreta (Barcelona) – #EASL2025
✅ Similar performance at inclusion & 48h
⚖️ No differences by sex or etiology
🔢 Cutoff: 232 ng/mL → Sens 73%, Spec 81%
📉 >232 predicts poor AKI resolution
🩺 Implement NGAL!
María José Moreta (Barcelona) – #EASL2025
✅ Similar performance at inclusion & 48h
⚖️ No differences by sex or etiology
🔢 Cutoff: 232 ng/mL → Sens 73%, Spec 81%
📉 >232 predicts poor AKI resolution
🩺 Implement NGAL!
May 9, 2025 at 3:00 PM
🧪 Urinary NGAL in AKI & decompensated cirrhosis
María José Moreta (Barcelona) – #EASL2025
✅ Similar performance at inclusion & 48h
⚖️ No differences by sex or etiology
🔢 Cutoff: 232 ng/mL → Sens 73%, Spec 81%
📉 >232 predicts poor AKI resolution
🩺 Implement NGAL!
María José Moreta (Barcelona) – #EASL2025
✅ Similar performance at inclusion & 48h
⚖️ No differences by sex or etiology
🔢 Cutoff: 232 ng/mL → Sens 73%, Spec 81%
📉 >232 predicts poor AKI resolution
🩺 Implement NGAL!
📊 EuroTIPS registry – Anna Baiges (Barcelona) at #EASL2025
Analysis of 1,334 cirrhotic patients with covered TIPS placement.
🧮 Common prognostic scores underperformed. New prognostic scores are needed
🌍 EuroTIPS is open to new centers — check the criteria to join!
👇 Slides
Analysis of 1,334 cirrhotic patients with covered TIPS placement.
🧮 Common prognostic scores underperformed. New prognostic scores are needed
🌍 EuroTIPS is open to new centers — check the criteria to join!
👇 Slides
May 9, 2025 at 2:58 PM
📊 EuroTIPS registry – Anna Baiges (Barcelona) at #EASL2025
Analysis of 1,334 cirrhotic patients with covered TIPS placement.
🧮 Common prognostic scores underperformed. New prognostic scores are needed
🌍 EuroTIPS is open to new centers — check the criteria to join!
👇 Slides
Analysis of 1,334 cirrhotic patients with covered TIPS placement.
🧮 Common prognostic scores underperformed. New prognostic scores are needed
🌍 EuroTIPS is open to new centers — check the criteria to join!
👇 Slides
🔬 The IMPuLCE Trial – Ewan Forrest (Glasgow) at #EASL2025
Phase 1b RCT of EBX-102, an oral pooled microbiota therapy in cirrhosis.
🧪 Innovative microbiome-based therapy
✅ Safe and well tolerated
🧬 Microbiome changes observed (↑ diversity)
👇 Slides
Phase 1b RCT of EBX-102, an oral pooled microbiota therapy in cirrhosis.
🧪 Innovative microbiome-based therapy
✅ Safe and well tolerated
🧬 Microbiome changes observed (↑ diversity)
👇 Slides
May 9, 2025 at 2:56 PM
🔬 The IMPuLCE Trial – Ewan Forrest (Glasgow) at #EASL2025
Phase 1b RCT of EBX-102, an oral pooled microbiota therapy in cirrhosis.
🧪 Innovative microbiome-based therapy
✅ Safe and well tolerated
🧬 Microbiome changes observed (↑ diversity)
👇 Slides
Phase 1b RCT of EBX-102, an oral pooled microbiota therapy in cirrhosis.
🧪 Innovative microbiome-based therapy
✅ Safe and well tolerated
🧬 Microbiome changes observed (↑ diversity)
👇 Slides
Do’s & Don’ts: NSAIDs & ASA in cirrhosis?
🗣️ Soňa Fraňková – #EASL2025
⚠️ NSAIDs: avoid — ↑ risk of bleeding & AKI
🔍 ASA: widely used, ↑ bleeding risk but retrospective data suggest survival benefit post-TIPS & ↓ HCC risk in MASLD -> More data needed!!
👇 Slides
🗣️ Soňa Fraňková – #EASL2025
⚠️ NSAIDs: avoid — ↑ risk of bleeding & AKI
🔍 ASA: widely used, ↑ bleeding risk but retrospective data suggest survival benefit post-TIPS & ↓ HCC risk in MASLD -> More data needed!!
👇 Slides
May 9, 2025 at 2:55 PM
Do’s & Don’ts: NSAIDs & ASA in cirrhosis?
🗣️ Soňa Fraňková – #EASL2025
⚠️ NSAIDs: avoid — ↑ risk of bleeding & AKI
🔍 ASA: widely used, ↑ bleeding risk but retrospective data suggest survival benefit post-TIPS & ↓ HCC risk in MASLD -> More data needed!!
👇 Slides
🗣️ Soňa Fraňková – #EASL2025
⚠️ NSAIDs: avoid — ↑ risk of bleeding & AKI
🔍 ASA: widely used, ↑ bleeding risk but retrospective data suggest survival benefit post-TIPS & ↓ HCC risk in MASLD -> More data needed!!
👇 Slides